Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Clements

Showing results (71-80 of 130) with videos related to

Pageof 13
Sort By:
Clinical Radiology|February 16, 2010
Lesion size is a major determinant of the mammographic features of ductal carcinoma in situ: findings from the Sloane projectA Evans, K Clements, A Maxwell, et al.
Cancer Research|October 19, 2007
Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progressionStephanie K Bunt, Linglin Yang, Pratima Sinha, et al.
British Journal of Cancer|September 13, 2007
Radiotherapy following breast-conserving surgery for screen-detected ductal carcinoma in situ: indications and utilisation in the UK. Interim findings from the Sloane ProjectD Dodwell, K Clements, G Lawrence, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1987
Allogeneic H-2 antigen expression is insufficient for tumor rejectionG A Cole, G A Cole, V K Clements, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 3, 2014
Variations in the management of the axilla in screen-detected ductal carcinoma in situ: evidence from the UK NHS breast screening programme audit of screen detected DCISS Nicholson, A Hanby, K Clements, et al.
Blood|April 1, 2011
Myeloid-derived suppressor cells express the death receptor Fas and apoptose in response to T cell-expressed FasLPratima Sinha, Olesya Chornoguz, Virginia K Clements, et al.
The British Journal of Surgery|March 12, 2021
Surgical decisions in older women with early breast cancer: patient and disease factorsY Jauhari, M R Gannon, D Dodwell, et al.
Journal of Leukocyte Biology|January 19, 2018
Frontline Science: High fat diet and leptin promote tumor progression by inducing myeloid-derived suppressor cellsVirginia K Clements, Tiha Long, Ramses Long, et al.
Cancer Research|March 18, 2004
Surgical removal of primary tumor reverses tumor-induced immunosuppression despite the presence of metastatic diseaseErika A Danna, Pratima Sinha, Mileka Gilbert, et al.
Journal of Leukocyte Biology|December 24, 2016
Frontline Science: Myeloid-derived suppressor cells (MDSCs) facilitate maternal-fetal tolerance in miceSuzanne Ostrand-Rosenberg, Pratima Sinha, Chas Figley, et al.
Pageof 13

Showing results (71-80 of 130) with videos related to

Sort By:
Pageof 13
Clinical Radiology|February 16, 2010
Lesion size is a major determinant of the mammographic features of ductal carcinoma in situ: findings from the Sloane projectA Evans, K Clements, A Maxwell, et al.
Cancer Research|October 19, 2007
Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progressionStephanie K Bunt, Linglin Yang, Pratima Sinha, et al.
British Journal of Cancer|September 13, 2007
Radiotherapy following breast-conserving surgery for screen-detected ductal carcinoma in situ: indications and utilisation in the UK. Interim findings from the Sloane ProjectD Dodwell, K Clements, G Lawrence, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1987
Allogeneic H-2 antigen expression is insufficient for tumor rejectionG A Cole, G A Cole, V K Clements, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 3, 2014
Variations in the management of the axilla in screen-detected ductal carcinoma in situ: evidence from the UK NHS breast screening programme audit of screen detected DCISS Nicholson, A Hanby, K Clements, et al.
Blood|April 1, 2011
Myeloid-derived suppressor cells express the death receptor Fas and apoptose in response to T cell-expressed FasLPratima Sinha, Olesya Chornoguz, Virginia K Clements, et al.
The British Journal of Surgery|March 12, 2021
Surgical decisions in older women with early breast cancer: patient and disease factorsY Jauhari, M R Gannon, D Dodwell, et al.
Journal of Leukocyte Biology|January 19, 2018
Frontline Science: High fat diet and leptin promote tumor progression by inducing myeloid-derived suppressor cellsVirginia K Clements, Tiha Long, Ramses Long, et al.
Cancer Research|March 18, 2004
Surgical removal of primary tumor reverses tumor-induced immunosuppression despite the presence of metastatic diseaseErika A Danna, Pratima Sinha, Mileka Gilbert, et al.
Journal of Leukocyte Biology|December 24, 2016
Frontline Science: Myeloid-derived suppressor cells (MDSCs) facilitate maternal-fetal tolerance in miceSuzanne Ostrand-Rosenberg, Pratima Sinha, Chas Figley, et al.
Pageof 13